Prevalence and Antimicrobial Susceptibility of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Intensive Care Units of Sanandaj General Hospitals (Kurdistan, Iran)

被引:27
作者
Ramazanzadeh, Rashid [1 ]
Chitsaz, Mohsen [2 ]
Bahmani, Nasrin [1 ]
机构
[1] Kurdistan Univ Med Sci, Fac Med, Dept Microbiol, Sanandaj 6617713446, Iran
[2] Shahed Univ, Fac Med, Dept Microbiol, Tehran, Iran
关键词
Extended-spectrum beta-lactamase; Intensive care units; Gram-negative bacteria; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; COMMUNITY-ONSET; RESISTANCE; ENTEROBACTERIACEAE; INFECTIONS; SURVEILLANCE; PATTERN; TEM;
D O I
10.1159/000224656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study focused on analyzing the spread of extended-spectrum beta-lactamase (ESBL) enzymes among Gram-negative bacteria at intensive care units (ICUs). Between January 2007 and January 2008, 301 consecutive clinical isolates of Gram-negative type were isolated. Of these, 66 strains were collected from patients in ICUs in two major hospitals in Sanandaj (Kurdistan, Iran). The isolates were identified, tested for antimicrobial susceptibility, and analyzed for the presence of ESBL using the double-disk synergy test. Isolates with a positive ESBL phenotype were subjected to PCR for SHV, TEM, OXA and CTX-M beta-lactamase gene families. Sixty-six Gram-negative bacteria were isolated from clinical samples of 66 ICU patients. These isolates included 16 Escherichia coli, 28 Enterobacter spp., 5 Pseudomonas spp., 10 Klebsiella pneumoniae, 3 Serratia marcescens and 1 Stenotrophomonas maltophilia. Twenty-three (34.85%) of these isolates were ESBL producing. The ESBL genes detected were SHV, TEM, OXA-1, OXA-2 and CTX-M. The results show the presence of ESBL genes among Gram-negative bacteria in the ICU setting of Sanandaj's hospitals. There is a need to institute a strict hospital infection control policy and regular surveillance of bacterial resistance to antimicrobial agents. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:287 / 292
页数:6
相关论文
共 33 条
  • [21] Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility
    Mendelson, G
    Hait, V
    Ben-Israel, J
    Gronich, D
    Granot, E
    Raz, R
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (01) : 17 - 22
  • [22] MIRSALEHIAN A, 2007, TEHRAN U MED J, V1, P33
  • [23] Klebsiella pneumomae isolate producing at least eight different β-lactamases, including AmpC and KPC β-lactamases
    Moland, Ellen Smith
    Hong, Seong Geun
    Thomson, Kenneth S.
    Larone, Davise H.
    Hanson, Nancy D.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 800 - 801
  • [24] Extended-spectrum β-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin
    Moreno, Andrea
    Bello, Helia
    Guggiana, Drago
    Dominguez, Mariana
    Gonzalez, Gerardo
    [J]. VETERINARY MICROBIOLOGY, 2008, 129 (1-2) : 203 - 208
  • [25] Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases:: Implications for the clinical microbiology laboratory
    Paterson, DL
    Ko, WC
    Von Gottberg, A
    Casellas, JM
    Mulazimoglu, L
    Klugman, KP
    Bonomo, RA
    Rice, LB
    McCormack, JG
    Yu, VL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) : 2206 - 2212
  • [26] Editorial response:: Extended-spectrum β-lactamases:: A call for improved detection and control
    Paterson, DL
    Yu, VL
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) : 1419 - 1422
  • [27] PATERSON DL, 1964, AM J INFECT CONTROL, V73, pS20
  • [28] Shahcheraghi F, 2007, MED SCI MONITOR, V13, pBR247
  • [29] Tonkic M, 2005, INT MICROBIOL, V8, P119
  • [30] Prevalence of extended-spectrum β-lactamases in South America
    Villegas, M. V.
    Kattan, J. N.
    Quinteros, M. G.
    Casellas, J. M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 154 - 158